Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit. Regulus Therapeutics to Present at the 2025 Oppenheimer Innovation on the Island Biotech Summit Post navigation Previous: Regulus Therapeutics Announces Successful Completion of its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of Farabursen (RGLS8429) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)Next: Regulus Therapeutics Enters into Agreement to be Acquired by Novartis AG
